Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB
Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
Vitiligo is a disease in which autoimmunity plays a major role. Multiple treatment options
are available, of which narrow-band UVB is a cornerstone, acting through immunosuppression
and repigmentation by stimulating reservoir melanocytes.
It's expected that this immunsupression is lower in darker skin types, where increased basal
melanin might act as a barrier.
Phase:
Phase 1
Details
Lead Sponsor:
Ain Shams University
Collaborators:
Alexandria University Assiut University Cairo University Menia University Suez Canal University